AI Reads Ultrasound Signals to Predict Which Carotid Plaques May Trigger Stroke

Every year, millions of people walk around with fatty deposits lodged in the walls of their neck arteries, unaware that some of these plaques are quietly dangerous while others will never cause harm. Ischemic stroke, the most common form of stroke, often begins when an unstable carotid plaque ruptures or sheds debris that blocks blood flow to the brain. The problem for clinicians has always been telling the difference between the two. Now, a prospective study published in BMC Medical Imaging by Chen Ni, Yun Li and colleagues in China suggests that machine learning, fed with a rich combination of advanced ultrasound measurements and routine clinical data, can sort vulnerable plaques from stable ones with clinically meaningful accuracy, offering a potential new tool for individualized stroke risk assessment.

The research team enrolled 231 hospital inpatients whose carotid plaques had been confirmed by ultrasound between December 2022 and December 2024. Rather than relying on symptoms alone, the investigators classified patients into an ischemic stroke group and a non-stroke group based on recent neuroimaging, giving the study an objective ground truth. The dataset was then randomly divided into a training cohort of 162 patients, on which the predictive models would learn, and an independent testing cohort of 69 patients, on which the models would be judged. This kind of strict separation between the data used to build a model and the data used to evaluate it is essential for demonstrating that a predictive tool generalizes beyond the patients it was trained on.

What sets this study apart from many earlier attempts at stroke prediction is the sheer richness of the ultrasound information it feeds into the algorithms. The researchers drew on four complementary ultrasound modalities. Conventional grayscale and Doppler ultrasound provided structural and hemodynamic information, including the thickness of each plaque. Shear wave elastography, or SWE, measured the stiffness of the plaque tissue, with particular attention paid to the region near the plaque shoulder, the junction between the plaque and the adjacent healthy arterial wall where ruptures frequently originate. Contrast-enhanced ultrasound, known as CEUS, used injected microbubble agents to reveal intraplaque neovascularization, the proliferation of tiny new blood vessels inside the plaque that is considered a hallmark of inflammation and instability. Alongside these imaging features, the team incorporated clinical parameters such as blood lipids and smoking history.

With dozens of candidate variables in hand, the researchers faced the classic statistical dilemma of modern medicine: too many features, too few patients. Their solution was a multi-stage feature selection pipeline designed to keep only the most robust predictors. First, they ran univariate logistic regression on each candidate variable and, in parallel, applied LASSO regression, a technique that shrinks the coefficients of weak predictors toward zero, validated with ten-fold cross-validation to guard against overfitting. Only variables that survived both analyses, appearing in the intersection of the two methods, advanced to the next round. Finally, a stepwise logistic regression procedure guided by the Akaike Information Criterion, a metric that balances model fit against model complexity, distilled the field down to five features.

Those five surviving predictors tell a coherent biological story. Plaque thickness, the simplest of the group, reflects how far the atherosclerotic lesion has progressed. Plaque stiffness measured by shear wave elastography at the near-shoulder region captures the mechanical vulnerability of the plaque’s most failure-prone zone. Intraplaque neovascularization detected by contrast-enhanced ultrasound signals active inflammation and fragile, leaky vessel growth within the lesion. Triglyceride levels and smoking history, both well-established cardiovascular risk factors, round out the picture by embedding each patient’s systemic metabolic and lifestyle context into the model. Notably, the algorithm did not simply reproduce the crude degree of arterial narrowing that has traditionally dominated stroke risk assessment; instead, it weighted the biological character of the plaque itself.

Using these five features, the team constructed and compared five different machine learning classifiers: logistic regression, k-nearest neighbors, support vector machine, decision tree, and random forest. Each algorithm approaches the prediction problem differently. Logistic regression draws a simple linear boundary between risk groups, while k-nearest neighbors classifies a patient by looking at the most similar cases in the training data. Support vector machines find the widest separating margin between classes, and decision trees split the data through a cascade of yes-or-no questions. Random forest, the eventual winner, builds hundreds of decision trees on random subsets of the data and averages their votes, a strategy that typically reduces the variance and overfitting to which single trees are prone.

On the independent testing set, the random forest model delivered the strongest performance, achieving an area under the receiver operating characteristic curve of 0.866. In practical terms, an AUC of 0.866 means the model distinguished stroke patients from non-stroke patients correctly in roughly 87 percent of random pairs, a level of discrimination the authors describe as robust. The model reached an overall accuracy of 0.81, with a sensitivity of 0.80, meaning it correctly flagged four out of five patients who had experienced an ischemic stroke, and a specificity of 0.83, meaning it correctly cleared most patients who had not. The team also employed decision curve analysis, a method that evaluates the net clinical benefit of a predictive model across a range of risk thresholds, to confirm that the model would be useful in real-world decision-making rather than merely impressive on paper.

Perhaps the most forward-looking element of the study is its use of SHAP, or SHapley Additive exPlanations, a technique borrowed from cooperative game theory that has become the standard for opening up the black box of machine learning in medicine. SHAP assigns each feature a contribution value for every individual prediction, revealing not just which variables matter overall but how they push each patient’s risk estimate up or down. When the researchers applied SHAP to their random forest model, plaque stiffness at the near-shoulder region emerged as the single largest contributor to the model’s output. Intriguingly, the analysis showed that lower SWE values, indicating softer plaque tissue in that critical shoulder zone, were associated with higher ischemic stroke risk, a finding consistent with the idea that lipid-rich, inflamed plaques are more prone to rupture than densely fibrotic ones.

The clinical implications are considerable. Carotid ultrasound is cheap, widely available, non-invasive and free of ionizing radiation, making it an ideal platform for risk screening if it can be made genuinely predictive. By layering elastography and contrast-enhanced imaging onto conventional ultrasound and letting machine learning integrate the results with basic clinical data, the approach described by Ni and colleagues could help physicians decide which patients with carotid plaques need aggressive medical therapy, closer surveillance, or referral for surgical intervention such as carotid endarterectomy, and which can be managed conservatively. The SHAP-based interpretability adds a layer of transparency that regulators and clinicians increasingly demand from medical artificial intelligence, since a risk score that cannot be explained is unlikely to be trusted at the bedside.

The authors are careful to frame the work as an adjunctive tool rather than a replacement for clinical judgment, and the study’s single-center design and modest sample size mean that external validation in larger, multi-ethnic cohorts will be needed before such models enter routine practice. The study was approved by the Institutional Review Board of Shaoxing People’s Hospital and conducted in accordance with the Declaration of Helsinki, with informed consent from all participants, and it was supported by health science research funding from Shaoxing and Zhejiang Province. Still, the convergence of multimodal ultrasound, rigorous feature selection and explainable machine learning marks a tangible step toward a future in which a routine neck scan does more than describe a plaque; it predicts what that plaque will do next, and helps prevent the stroke before it happens.

Subject of Research: Machine learning prediction of ischemic stroke risk from multimodal ultrasound and clinical features in patients with carotid plaques

Article Title: Machine learning models combining multimodal ultrasound and clinical factors for predicting ischemic stroke risk in patients with carotid plaques

Article References: Ni, C., Li, Y., Jiang, Y., Zhu, J., Ni, J., Ruan, Y., Zhao, S., & Liu, X. (2026). Machine learning models combining multimodal ultrasound and clinical factors for predicting ischemic stroke risk in patients with carotid plaques. BMC Medical Imaging. https://doi.org/10.1186/s12880-026-02754-w

Image Credits: AI Generated

DOI: 10.1186/s12880-026-02754-w

Keywords: ischemic stroke, carotid plaque, machine learning, random forest, shear wave elastography, contrast-enhanced ultrasound, plaque vulnerability, SHAP, risk prediction, medical imaging, predictive medicine, ultrasound